Recent insider trading activity from MacLean Alexandra, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 23, 2024 | AVENUE THERAPEUTICS, INC. | $ATXI | MacLean Alexandra | Chief Executive Officer | A | COMMON STOCK, PAR VALUE $0.0001 | 170000 | $0.00 | 170,000.0000 | 341,324 | 9999.99% | 49.81% |
| June 29, 2023 | AVENUE THERAPEUTICS, INC. | $ATXI | MacLean Alexandra | Chief Executive Officer | A | Employee stock option (right to buy) | 800000 | $0.00 | 800,000.0000 | 0 | 9999.99% | 0.00% |